Key terms

About SMMT

Summit Therapeutics, Inc. a biopharmaceutical company, which discovers, develops, and commercializes medicines to treat infectious diseases. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Menlo Park, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SMMT news

Apr 11 4:52pm ET Summit Therapeutics Appoints Biotech Veteran to Board by TipRanks Apr 03 4:52pm ET Summit Therapeutics Announces Major Leadership Restructuring by TipRanks Mar 27 8:44pm ET Summit Therapeutics CFO buy $375K in common stock by TipRanks Mar 27 8:44pm ET Summit Therapeutics CEO buys $411K in common stock by TipRanks Mar 25 4:25pm ET Summit Therapeutics’ Ivonescimab: A Potential New Standard in Oncology Market Challenging Keytruda by TipRanks Mar 25 4:14pm ET Summit Therapeutics initiated with a Buy at Stifel by TipRanks Mar 22 7:13am ET Summit presents ivonescimab data at 2024 European Lung Cancer Congress by TipRanks Mar 12 8:52am ET Summit Therapeutics Showcases at Barclays Healthcare Conference by TipRanks Feb 27 4:35am ET SHAREHOLDER ALERT: Potential Recovery for Summit Therapeutics Inc. (SMMT) Investors by TipRanks Feb 23 11:04am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 22 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 20 7:57am ET Summit Therapeutics files to sell 2.98M shares of common stock for holders by TipRanks Feb 20 7:57am ET Summit Therapeutics files $450M mixed securities shelf by TipRanks Feb 15 5:43pm ET Summit Therapeutics Highlights Innovations at Healthcare Conference by TipRanks Feb 09 4:38am ET Summit Therapeutics Presents at Annual Healthcare Conference by TipRanks Jan 19 11:24am ET Biotech Alert: Searches spiking for these stocks today by TipRanks
Mar 29 5:43pm ET Why Summit Therapeutics Stock Crushed the Market This Week by Motley Fool

No recent press releases are available for SMMT

SMMT Financials

1-year income & revenue

Key terms

SMMT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SMMT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel